Tag: Jeff Aronin

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Jeff Aronin

Emalex Biosciences Raises $35 Million in Series C Preferred Stock to Advance Tourette Syndrome ...

Added to Collection on: 2021-03-23 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Can the vaccine alleviate COVID long-haul symptoms? • Mercy sale approved • UChicago cancer ...

Added to Collection on: 2021-03-24 10:07:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Paragon Biosciences' CEO Jeff Aronin Names Jordan Dubow New Chief Medical Officer

Added to Collection on: 2021-04-15 20:59:42

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Paragon Biosciences' CEO Jeff Aronin Announces $35 Million Series C Preferred Stock Raise for ...

Added to Collection on: 2021-04-19 17:03:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Jeff Aronin on Booming Life Sciences Success in Chicago

Added to Collection on: 2021-05-03 15:11:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Mansueto, Polsky back Northwestern biotech spinout

Added to Collection on: 2021-05-06 16:30:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Jeff Aronin Announces Matthew Gantz as CEO of Castle Creek Biosciences

Added to Collection on: 2021-05-11 18:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Sai Chavala, MD, Receives ARVO Foundation Ludwig Von Sallmann Clinician-Scientist Award

Added to Collection on: 2021-06-03 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Paragon Biosciences' Jeff Aronin Supporting Trials for the Treatment of Tourette Syndrome, Stuttering

Added to Collection on: 2021-07-08 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Emalex Closes $250M Series D to Fund Phase III Trial in Tourette Syndrome | BioSpace

Added to Collection on: 2022-11-03 15:10:23

Tags for this article:

Click the tags to see associated articles and topics

View Article Details